Quadrant Capital »

Larimar Therapeutics shares owned by Quadrant Capital

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.4k 370 6.55

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Scp Etf (IJR)
Procter & Gamble Company (PG)
NVIDIA Corporation (NVDA)
Ishares Core Msci Emkt (IEMG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Eafe Sml Cp Etf (SCZ)
Target Corporation (TGT)

View all positions for Quadrant Capital

Top funds holding Larimar Therapeutics

Deerfield Management Company
RA Capital Management
Henderson Group
Goldman Sachs Group
Blue Owl Capital Holdings
BlackRock
Vanguard Group
Adage Capital Partners GP
Driehaus Capital Management
Woodline Partners
Verition Fund Management
State Street Corporation
Geode Capital Management
Altium Capital Management
Mangrove Partners

View all funds holding Larimar Therapeutics